# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Nexalin Technology, Inc. (NASDAQ:NXL, NXLIW))))Ā (the "Company" or "Nexalin") today announced the pricing of a p...
- SEC Filing We are offering on a reasonable best effort basis up to $7,000,000 of our common stock, $0.001 par value per shar...
Study demonstrates strong statistical separation between patients receiving Nexalin's DIFSĀ® technology in combination with ...
https://www.youtube.com/watch?v=6nIaEXjW_uI
- SEC Filing
Nexalin Technology, Inc. (NASDAQ: NXL) shares surged on Friday afternoon following the announcement of a new patent awarded by ...